Wealthspire Advisors (New York)’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
KK
AC
WCM
N
RA
Wealthspire Advisors (New York)'s ANGO Position: Q4 2025 in Review
Wealthspire Advisors (New York) sold out of AngioDynamics (ANGO) in Q4 2025, closing a stake of 93 shares — an estimated $1.04K sold.
Wealthspire Advisors (New York) first reported a position in ANGO in Q3 2025 and held it in 1 quarter. The position peaked at $1.04K in Q3 2025. 167 funds tracked by Wall St. Rank hold ANGO as of Q4 2025.
- Wealthspire Advisors (New York) reported no remaining AngioDynamics position as of Q4 2025 after selling out during the quarter.
- Wealthspire Advisors (New York) sold 93 AngioDynamics shares in Q4 2025, an estimated $1.04K.
- Wealthspire Advisors (New York) first reported a position in AngioDynamics in Q3 2025 and held it in 1 quarter.
- Wealthspire Advisors (New York)'s AngioDynamics position peaked at $1.04K in Q3 2025.
- 167 funds tracked by Wall St. Rank held AngioDynamics as of Q4 2025.
Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.